Trademarkia Logo

Australia

AU$
ENGTR1S
Protected: Registered/protected

Last updated on 26 Jan 2023

Owner Info

GentiBio Inc.

150 CambridgePark Drive, 9th Floor

Cambridge MA 02140, UNITED STATES OF AMERICA

Serial Number

2251624 filed on 14 Jan 2022

Correspondent

John V. Hobgood, Esquire Wilmer Cutler Pickering Hale and Dorr LLP

60 State Street,

Boston MA 02109,

UNITED STATES OF AMERICA

ENGTR1S

Classification Information


Class [005]
Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; pharmaceutical preparations for use in the treatment of autoimmun Read More

Class [040]
Custom manufacture of pharmaceuticals for others; custom manufacturing and engineering of biological cells.

Class [042]
Scientific research; pharmaceutical research; medical research; technological consultation services in the fields of manufacturing pharmaceuticals and Read More

Mark Details


Serial Number

2251624

Registered On

14 Jan 2022

Renewal On

14 Jan 2032

Mark Type

WORD

Priority Claim (Convention Details)


Date

14 Jul 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
26th Jan 2023Amendment to Amend Owner Requested
10th May 2022International Registration in Australia Protected correspondence sent
9th May 2022IP Right Registration Published
9th May 2022Status change to Registered/Protected
3rd Mar 2022Application Accepted correspondence sent
2th Mar 2022IP Right has been Examined
2th Mar 2022IP Right Acceptance Published
2th Mar 2022Status change to Accepted
1st Mar 2022Examination expedited
1st Mar 2022Awaiting examination